- Home
- WBX vs VOR Comparison
WBX vs VOR Comparison
Compare WBX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- VOR
- Stock Information
- Founded
- WBX 2015
- VOR 2015
- Country
- WBX Spain
- VOR United States
- Employees
- WBX N/A
- VOR N/A
- Industry
- WBX Industrial Specialties
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- WBX Consumer Discretionary
- VOR Health Care
- Exchange
- WBX Nasdaq
- VOR Nasdaq
- Market Cap
- WBX 102.7M
- VOR 85.7M
- IPO Year
- WBX N/A
- VOR 2021
- Fundamental
- Price
- WBX $0.30
- VOR $0.18
- Analyst Decision
- WBX Buy
- VOR Buy
- Analyst Count
- WBX 3
- VOR 7
- Target Price
- WBX $0.75
- VOR $7.83
- AVG Volume (30 Days)
- WBX 275.9K
- VOR 4.6M
- Earning Date
- WBX 05-07-2025
- VOR 05-27-2025
- Dividend Yield
- WBX N/A
- VOR N/A
- EPS Growth
- WBX N/A
- VOR N/A
- EPS
- WBX N/A
- VOR N/A
- Revenue
- WBX $171,352,140.00
- VOR N/A
- Revenue This Year
- WBX N/A
- VOR N/A
- Revenue Next Year
- WBX $43.72
- VOR N/A
- P/E Ratio
- WBX N/A
- VOR N/A
- Revenue Growth
- WBX 3.75
- VOR N/A
- 52 Week Low
- WBX $0.25
- VOR $0.15
- 52 Week High
- WBX $1.64
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- WBX 33.33
- VOR 19.39
- Support Level
- WBX $0.35
- VOR $0.15
- Resistance Level
- WBX $0.40
- VOR $0.27
- Average True Range (ATR)
- WBX 0.03
- VOR 0.06
- MACD
- WBX -0.01
- VOR -0.04
- Stochastic Oscillator
- WBX 30.55
- VOR 8.00
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.